Page last updated: 2024-08-21

pyrimidine and levoleucovorin

pyrimidine has been researched along with levoleucovorin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Burge, M; Clarke, S; Cordwell, C; Gibbs, P; Reece, W; Tebbutt, N1
Taieb, J; Zaanan, A1
Andersson, O; Bertolino, P; Cesta, CE; Duan, L; Karampelias, C; Korbutt, GS; Liu, X; Lu, J; Pazzagli, L; Rezanejad, H; Rosko, M1
Armisén, R; Bravo, ML; Cordova-Delgado, M; Corvalán, AH; Cumsille, E; Garrido, M; Hill, CN; Lavanderos, MA; Li, Z; Liao, Y; Miquel, JF; Muñoz-Medel, M; Owen, GI; Pinto, MP; Quiñones, LA; Retamal, IN; Rodriguez-Fernandez, M1
Boku, N; Esaki, T; Izawa, N; Kawakami, K; Kawakami, T; Komoda, M; Makiyama, A; Masuishi, T; Mitani, S; Moriwaki, T; Nagashima, K; Nakajima, TE; Okuda, H; Tsuji, Y; Yamamoto, S; Yamamoto, Y; Yamazaki, K1

Reviews

1 review(s) available for pyrimidine and levoleucovorin

ArticleYear
[Predictive and prognostic value of MSI phenotype in adjuvant colon cancer: Who and how to treat?]
    Bulletin du cancer, 2019, Volume: 106, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Immunotherapy; Leucovorin; Lymphocytes, Tumor-Infiltrating; Microsatellite Instability; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Phenotype; Prognosis; Pyrimidines

2019

Trials

1 trial(s) available for pyrimidine and levoleucovorin

ArticleYear
An Australian translational study to evaluate the prognostic role of inflammatory markers in patients with metastatic ColorEctal caNcer Treated with bevacizumab (Avastin™) [ASCENT].
    BMC cancer, 2013, Mar-15, Volume: 13

    Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Camptothecin; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Inflammation; Leucovorin; Lymphocytes; Male; Neutrophils; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Prognosis; Proportional Hazards Models; Prospective Studies; Pyrimidines; Reproducibility of Results

2013

Other Studies

3 other study(ies) available for pyrimidine and levoleucovorin

ArticleYear
Reinforcing one-carbon metabolism via folic acid/Folr1 promotes β-cell differentiation.
    Nature communications, 2021, 06-07, Volume: 12, Issue:1

    Topics: Animals; Animals, Genetically Modified; Animals, Newborn; Carbon; Carnitine; Cell Differentiation; Cells, Cultured; Folate Receptor 1; Gene Expression Regulation; Humans; Insulin-Secreting Cells; Larva; Leucovorin; Metabolic Networks and Pathways; Mice; Pyrimidines; Swine; Zebrafish

2021
A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer.
    BMC cancer, 2021, Sep-16, Volume: 21, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Case-Control Studies; Confidence Intervals; Dihydrouracil Dehydrogenase (NADP); DNA-Binding Proteins; Endonucleases; Female; Fluorouracil; Gene Frequency; Genes, p53; Genotype; Glutathione S-Transferase pi; Glycine Hydroxymethyltransferase; Humans; Leucovorin; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Multienzyme Complexes; Nomograms; Odds Ratio; Organoplatinum Compounds; Orotate Phosphoribosyltransferase; Orotidine-5'-Phosphate Decarboxylase; Platinum Compounds; Polymorphism, Single Nucleotide; Pyrimidines; Quality of Life; Retrospective Studies; Stomach Neoplasms; Xeroderma Pigmentosum Group D Protein

2021
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.
    BMC cancer, 2021, Oct-29, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Angiogenesis Inhibitors; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Disease Progression; Drug Administration Schedule; Female; Fluorouracil; Humans; Irinotecan; Japan; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Progression-Free Survival; Pyrimidines; Retrospective Studies; Time Factors

2021